¼¼°èÀÇ ÀÎÅ¥º£ÀÌÅÍ ¼ÎÀÌÄ¿ ½ÃÀå
Incubator Shaker
»óǰÄÚµå : 1798916
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 221 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,233,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,701,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ÀÎÅ¥º£ÀÌÅÍ ¼ÎÀÌÄ¿ ½ÃÀåÀº 2030³â±îÁö 3¾ï 6,460¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 3¾ï 1,610¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ÀÎÅ¥º£ÀÌÅÍ ¼ÎÀÌÄ¿ ½ÃÀåÀº 2024-2030³âÀÇ ºÐ¼® ±â°£¿¡ CAGR 2.4%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 3¾ï 6,460¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ Ç÷ξîÇü ÁøÅÁ ÀÎÅ¥º£ÀÌÅÍ Á¦Ç°Àº CAGR 2.0%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 2¾ï 370¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º¥Ä¡Å¾Çü ÁøÅÁ ÀÎÅ¥º£ÀÌÅÍ Á¦Ç° ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 2.8%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 8,610¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 4.6%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ÀÎÅ¥º£ÀÌÅÍ ¼ÎÀÌÄ¿ ½ÃÀåÀº 2024³â¿¡ 8,610¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀ» 4.6%·Î, 2030³â±îÁö 6,940¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 0.9%¿Í 1.8%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 1.3%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ÀÎÅ¥º£ÀÌÅÍ ¼ÎÀÌÄ¿ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ÀÎÅ¥º£ÀÌÅÍ ¼ÎÀÌÄ¿°¡ Çö´ë »ý¹°ÇÐ ¿¬±¸ ¹× °Ë»ç¿¡ ÇʼöÀûÀÎ ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

ÀÎÅ¥º£ÀÌÅÍ ½¦ÀÌÄ¿´Â ¿Âµµ¿Í ´ë±â¸¦ Á¦¾îÇÑ Á¶°Ç¿¡¼­ ½Ã·áÀÇ ¹è¾ç°ú ±³¹ÝÀ» µ¿½Ã¿¡ ¼öÇàÇÏ´Â µ¥ »ç¿ëµÇ´Â Áß¿äÇÑ ½ÇÇè ÀåºñÀÔ´Ï´Ù. ¹Ì»ý¹°ÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¼¼Æ÷¹è¾ç, Á¦¾à½ÃÇè µî ±ÕÀÏÇÑ È¥ÇÕ°ú ÃÖÀûÀÇ Áõ½Ä ȯ°æÀÌ ¿ä±¸µÇ´Â ºÐ¾ß¿¡¼­ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÎÅ¥º£ÀÌÅÍ ½¦ÀÌÄ¿´Â ¾ÈÁ¤ÀûÀÎ ¼¼Æ÷ Áõ½Ä, ´Ü¹éÁú ¹ßÇö, ¹è¾ç ±ÕÀϼºÀ» º¸ÀåÇÏ¿© °úÇÐ ¿¬±¸ ¹× ÀÓ»ó °³¹ß¿¡ ÇʼöÀûÀÎ ÅøÀÌ µÇ¾ú½À´Ï´Ù.

Á¦¾àȸ»ç ¹× »ý¸í°øÇÐ ¿¬±¸¼Ò¿¡¼­´Â ÀÎÅ¥º£ÀÌÅÍ Áøµ¿±â´Â ¹ÚÅ׸®¾Æ ¹× È¿¸ð ¹è¾ç, ¹ßÈ¿ ½ÃÇè, ÀçÁ¶ÇÕ ´Ü¹éÁú »ý»ê¿¡ »ç¿ëµË´Ï´Ù. Çмú±â°ü ¹× À§Å¹¿¬±¸±â°ü(CRO)¿¡¼­µµ DNA/RNA ÃßÃâ, È¿¼Ò Ȱ¼º ºÐ¼®, ¹Ì»ý¹° ½ºÅ©¸®´×¿¡ Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. »ý¸í°úÇÐ ¿¬±¸°¡ Àü ¼¼°è¿¡¼­ È®´ëµÇ°í ´õ º¹ÀâÇÑ »ý¹°ÇÐÀû ÇÁ·ÎÅäÄÝÀÌ Ã¤Åõʿ¡ µû¶ó Á¤È®Çϰí ÀÚµ¿È­µÈ ¹è¾ç ¹× È¥ÇÕ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä´Â Áö¼ÓÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

µðÀÚÀΠƯ¼º°ú ±â´É¼ºÀº ¾î¶»°Ô ÁøÈ­Çϰí Àִ°¡?

ÃֽŠÀÎÅ¥º£ÀÌÅÍ ¼ÎÀÌÄ¿´Â ÇÁ·Î±×·¡¹Ö, ¿Âµµ ¾ÈÁ¤¼º, °¡º¯ ¼Óµµ Á¦¾î¸¦ °­È­ÇÑ ¼³°è·Î µÇ¾î ÀÖ½À´Ï´Ù. °í±Þ ¸ðµ¨Àº µðÁöÅÐ ÀÎÅÍÆäÀ̽º, ÇÁ·Î±×·¡¹Ö °¡´ÉÇÑ ÀÛµ¿ ÁÖ±â, »ç¿ëÀÚ Á¤ÀÇ ±³¹Ý ÇÁ·ÎÆÄÀÏÀ» Á¦°øÇÏ¿© º¹ÀâÇÑ ½ÇÇè ¿öÅ©Ç÷ο츦 Áö¿øÇÕ´Ï´Ù. ¿Âµµ, ½Àµµ, CO2 ¼öÁØÀÇ Á¤¹ÐÇÑ Á¦¾î´Â ƯÈ÷ Æ÷À¯·ù ¹× ¹Î°¨ÇÑ ¹Ì»ý¹° ¹è¾ç¿¡ À־´Â ÀÌÁ¦ Ç¥ÁØÀÌ µÇ¾ú½À´Ï´Ù. ±Ëµµ, ¿Õº¹, µà¾ó ¸ð¼Ç ¿É¼ÇÀ» °®Ãá ¸ðµ¨Àº ´Ù¾çÇÑ ½ÇÇè ÇÁ·ÎÅäÄÝ¿¡ À¯¿¬ÇÏ°Ô ´ëÀÀÇÒ ¼ö ÀÖ½À´Ï´Ù.

³»½Ä¼º ÀÎÅ׸®¾î, Áøµ¿ °¨¼è Ç÷§Æû, UV ³»¼º â µîÀÇ ¼ÒÀç °³¼±À¸·Î ³»±¸¼º°ú ¿À¿° Á¦¾î°¡ Çâ»óµÇ¾ú½À´Ï´Ù. ¼³Ä¡ °ø°£ÀÇ Á¦¾àÀÌ ¿ì·ÁµÇ´Â ÇÏÀ̽º·çDz ½ÇÇè½Ç¿¡¼­´Â ½×À» ¼ö ÀÖ´Â °ø°£ Àý¾àÇü ¼³°è¸¦ äÅÃÇÏ´Â °æ¿ì°¡ ´Ã°í ÀÖ½À´Ï´Ù. ¿¡³ÊÁö È¿À²ÀÌ ³ôÀº ºÎǰ°ú ¼ÒÀ½ °¨¼Ò ½Ã½ºÅÛÀº °ø¿ë ½ÇÇè½Ç °ø°£ÀÇ »ç¿ë ÆíÀǼºÀ» Çâ»ó½Ãŵ´Ï´Ù. ÀÌ·¯ÇÑ °³¹ß·Î ÀÎÇØ ÀÎÅ¥º£ÀÌÅÍ Áøµ¿±â´Â Áý¾àÀûÀÎ ¿¬±¸ ȯ°æ¿¡¼­ ´õ¿í ÀûÀÀ·ÂÀÌ ¶Ù¾î³ª°í °ß°íÇÏ¸ç ½Å·ÚÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

½ÃÀå ¼ö¿ä´Â ¾îµð¿¡¼­ ¼ºÀåÇϰí ÀÖÀ¸¸ç, ¾î¶² ºÎ¹®¿¡¼­ äÅÃÀÌ ÁøÇàµÇ°í Àִ°¡?

ÀÎÅ¥º£ÀÌÅÍ ¼ÎÀÌÄ¿ ½ÃÀå ¼ö¿ä´Â »ý¸í°øÇÐ, Á¦¾à, Çмú, ½Äǰ °Ë»ç½Ç¿¡¼­ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. »ý¸í°øÇÐ ±â¾÷Àº ¼¼Æ÷ÁÖ °³¹ß, À¯ÀüÀÚ ÆíÁý ¿öÅ©Ç÷οì, ´Ü¹éÁú Á¤Á¦¿¡ ÀÎÅ¥º£ÀÌÅÍ Áøµ¿À» Ȱ¿ëÇϰí ÀÖ½À´Ï´Ù. Á¦¾àȸ»çµéÀº ¾÷½ºÆ®¸² °øÁ¤ °³¹ß ¹× ¹Ì»ý¹° ¹ßÈ¿ ¿¬±¸¿¡ ÀÎÅ¥º£ÀÌÅÍ Áøµ¿±â¸¦ »ç¿ëÇϰí ÀÖ½À´Ï´Ù. ½Äǰ ¹× À½·á ¿¬±¸¼Ò´Â ¹Ì»ý¹° ¿À¿° ½ÃÇè°ú È¿¸ð Áõ½Ä¿¡ ÀÌ Àåºñ¸¦ »ç¿ëÇϰí ÀÖ½À´Ï´Ù.

Áö¿ªÀûÀ¸·Î´Â ºÏ¹Ì¿Í À¯·´ÀÌ °­·ÂÇÑ R&D ÀÎÇÁ¶ó¿Í »ý¸í°úÇп¡ ´ëÇÑ ÅõÀÚ·Î ÀÎÇØ ¿©ÀüÈ÷ ÁÖ¿ä ½ÃÀåÀ¸·Î ³²¾ÆÀÖ½À´Ï´Ù. ±×·¯³ª ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¹ÙÀÌ¿ÀÀǾàǰ »ý»ê Áõ°¡, Àӻ󿬱¸ ¾Æ¿ô¼Ò½Ì, ÇмúÀû ÀÚ±Ý Áö¿øÀ¸·Î ÀÎÇØ ±Þ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. º´¿øÀ̳ª Áø´Ü ½ÇÇè½Ç¿¡¼­µµ º´¿ø±Õ ¹è¾çÀ̳ª Ç×±ÕÁ¦ °¨¼ö¼º °Ë»ç¸¦ À§ÇØ ¼Ò±Ô¸ð ÀÎÅ¥º£ÀÌÅÍ ¼ÎÀÌÄ¿¸¦ µµÀÔÇϰí ÀÖ½À´Ï´Ù. Áúº´ °¨½Ã, ¹é½Å °³¹ß, ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ³ë·ÂÀÌ È®´ëµÊ¿¡ µû¶ó ¹ü¿ë¼º ³ôÀº ÀÚµ¿ ¹è¾çÀåÄ¡¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ÀÎÅ¥º£ÀÌÅÍ ¼ÎÀÌÄ¿ ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº?

ÀÎÅ¥º£ÀÌÅÍ ¼ÎÀÌÄ¿ ½ÃÀåÀÇ ¼ºÀåÀº »ý¸í°úÇÐ ¿¬±¸ Ȱµ¿ÀÇ È°¼ºÈ­, È¿À²ÀûÀ̰í È®Àå °¡´ÉÇÑ ¼¼Æ÷¹è¾ç ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä, Àåºñ ÀÚµ¿È­ ¹× ȯ°æ Á¦¾îÀÇ ±â¼ú ¹ßÀü µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ÇÁ·Î±×·¡¸Óºí ·ÎÁ÷, ½Ç½Ã°£ ¸ð´ÏÅ͸µ, ¿Âµµ ±ÕÀϼº Çâ»óÀ¸·Î ½ÇÇèÀÇ ÀçÇö¼º°ú 󸮷®ÀÌ Çâ»óµÇ¾ú½À´Ï´Ù. ½ÇÇè½Ç Á¤º¸ °ü¸® ½Ã½ºÅÛ(LIMS) ¹× µ¥ÀÌÅÍ ¼öÁý Ç÷§Æû°úÀÇ ÅëÇÕÀº ±ÔÁ¦ ȯ°æ¿¡¼­ÀÇ ÃßÀû¼º ¹× ÄÄÇöóÀ̾𽺸¦ Áö¿øÇÕ´Ï´Ù.

¹ÙÀÌ¿ÀÀǾàǰ ¿¬±¸°³¹ß, Çмú¿¬±¸, Áø´Ü, »ê¾÷ ¹Ì»ý¹°ÇÐ µî ÃÖÁ¾ ¿ëµµÀÇ È®´ë·Î ÀÎÅ¥º£ÀÌÅÍ Áøµ¿ÀÇ ÀÀ¿ë ¹üÀ§°¡ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ´Ü¹éÁú Ä¡·áÁ¦, ¹é½Å, ¹Ì»ý¹° ¹ÙÀÌ¿À Á¦Ç°ÀÌ ´õ¿í º¹ÀâÇØÁü¿¡ µû¶ó ½ÇÇè½Ç¿¡¼­´Â ½Å·ÚÇÒ ¼ö ÀÖ´Â ¹è¾ç Á¶°ÇÀ» º¸ÀåÇÏ´Â Àåºñ°¡ ÇÊ¿äÇÕ´Ï´Ù. Áøµ¿±â ¼³°è, ¸ð¼Ç Á¦¾î, ¸ÖƼ è¹ö ½Ã½ºÅÛÀÇ ±â¼ú Çõ½ÅÀº ÀÌ·¯ÇÑ ÁøÈ­ÇÏ´Â ¿ä±¸¿¡ ºÎÀÀÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ¿¬±¸ ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÀÚ±Ý Áö¿ø Áõ°¡ ¹× ÀÚµ¿È­·ÎÀÇ Àüȯ°ú ÇÔ²² ¼¼°è ÀÎÅ¥º£ÀÌÅÍ ¼ÎÀÌÄ¿ ½ÃÀåÀÇ Áö¼ÓÀûÀÎ ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(Ç÷ξîÇü ÁøÅÁ ÀÎÅ¥º£ÀÌÅÍ Á¦Ç°, º¥Ä¡Å¾Çü ÁøÅÁ ÀÎÅ¥º£ÀÌÅÍ Á¦Ç°, ÀÎÅ¥º£ÀÌÆ® ¹Ì´Ï ¼ÎÀÌÄ¿ Á¦Ç°), ¾ÖÇø®ÄÉÀ̼Ç(ÀǾàǰ ¾ÖÇø®ÄÉÀ̼Ç, ¹ÙÀÌ¿À¿¬·á ¾ÖÇø®ÄÉÀ̼Ç, ¹Ì»ý¹°ÇÐ ¾ÖÇø®ÄÉÀ̼Ç, ¼¼Æ÷¹è¾ç ¾ÖÇø®ÄÉÀ̼Ç, ÀǾàǰ °³¹ß ¾ÖÇø®ÄÉÀ̼Ç, ¹ÙÀÌ¿ÀÇÁ·Î¼¼½Ì ¾ÖÇø®ÄÉÀ̼Ç, ¼¼±ÕÇÐ ¾ÖÇø®ÄÉÀ̼Ç, ±âŸ ¾ÖÇø®ÄÉÀ̼Ç)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Incubator Shaker Market to Reach US$364.6 Million by 2030

The global market for Incubator Shaker estimated at US$316.1 Million in the year 2024, is expected to reach US$364.6 Million by 2030, growing at a CAGR of 2.4% over the analysis period 2024-2030. Floor Model Shaking Incubator Product, one of the segments analyzed in the report, is expected to record a 2.0% CAGR and reach US$203.7 Million by the end of the analysis period. Growth in the Benchtop Shaking Incubator Product segment is estimated at 2.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$86.1 Million While China is Forecast to Grow at 4.6% CAGR

The Incubator Shaker market in the U.S. is estimated at US$86.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$69.4 Million by the year 2030 trailing a CAGR of 4.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.9% and 1.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.3% CAGR.

Global Incubator Shaker Market - Key Trends & Drivers Summarized

Why Are Incubator Shakers Critical in Modern Biological Research and Testing?

Incubator shakers are essential laboratory devices used for simultaneous incubation and agitation of samples under controlled temperature and atmospheric conditions. They are widely employed in microbiology, molecular biology, cell culture, and pharmaceutical testing where uniform mixing and optimal growth environments are required. Incubator shakers ensure consistent cell proliferation, protein expression, and culture homogeneity, making them vital tools for scientific research and clinical development.

In pharmaceutical and biotech labs, incubator shakers are used for bacterial and yeast cultivation, fermentation studies, and recombinant protein production. Academic institutions and contract research organizations (CROs) also rely on them for DNA/RNA extraction, enzyme activity assays, and microbial screening. As life science research expands globally and more complex biological protocols are adopted, demand for precise, automated incubation and mixing solutions continues to rise.

How Are Design Features and Functional Capabilities Evolving?

Modern incubator shakers are being designed with enhanced programmability, temperature stability, and variable speed control. Advanced models offer digital interfaces, programmable run cycles, and user-defined agitation profiles to support complex experimental workflows. Precision control of temperature, humidity, and CO2 levels is now standard, especially for mammalian and sensitive microbial cultures. Models with orbital, reciprocating, and dual-motion options provide flexibility for various laboratory protocols.

Material improvements such as corrosion-resistant interiors, vibration-dampening platforms, and UV-resistant windows are improving durability and contamination control. Stackable and space-saving designs are increasingly adopted in high-throughput laboratories, where footprint constraints are a concern. Energy-efficient components and noise-reduction systems are enhancing usability in shared lab spaces. These developments are making incubator shakers more adaptable, robust, and reliable across intensive research environments.

Where Is Market Demand Growing and Which Segments Are Leading Adoption?

Market demand for incubator shakers is growing in biotechnology, pharmaceutical, academic, and food testing laboratories. Biotech companies rely on them for cell line development, gene editing workflows, and protein purification. Drug manufacturers use incubator shakers in upstream process development and microbial fermentation studies. Food and beverage labs employ these devices for microbial contamination testing and yeast propagation.

Geographically, North America and Europe remain leading markets due to strong R&D infrastructure and investment in life sciences. However, Asia Pacific is seeing rapid growth, driven by increased biopharma production, clinical research outsourcing, and academic funding. Hospitals and diagnostic labs are also deploying small-scale incubator shakers for pathogen culture and antimicrobial susceptibility testing. As disease surveillance, vaccine development, and personalized medicine initiatives expand, so does the need for versatile, automated incubation equipment.

What Is Driving Growth in the Incubator Shaker Market?

Growth in the incubator shaker market is driven by several factors including increased life science research activity, demand for efficient and scalable cell culture systems, and technological advancements in device automation and environmental control. Improvements in programmable logic, real-time monitoring, and temperature uniformity are enhancing experimental reproducibility and throughput. Integration with laboratory information management systems (LIMS) and data capture platforms is supporting traceability and compliance in regulated environments.

End-use expansion across biopharma R&D, academic research, diagnostics, and industrial microbiology is broadening the application scope for incubator shakers. As protein therapeutics, vaccines, and microbial bio-products become more complex, laboratories require devices that ensure reliable culture conditions. Innovation in shaker design, motion control, and multi-chamber systems is meeting these evolving demands. These developments, combined with increased funding for research infrastructure and a shift toward automation, are driving sustained growth in the global incubator shaker market.

SCOPE OF STUDY:

The report analyzes the Incubator Shaker market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Floor Model Shaking Incubator Product, Benchtop Shaking Incubator Product, Incubating Mini Shaker Product); Application (Pharmaceuticals Application, Biofuel Application, Microbiology Application, Cell Culture Application, Drug Development Application, Bio-Processing Application, Bacteriology Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â